Perimeter Medical Imaging AI to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
Perimeter Medical Imaging AI, Inc. (TSXV: PINK, OTC: PYNKF) announced its participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25-26, 2023, in Toronto. The company, focused on revolutionizing cancer surgery through advanced imaging technologies, aims to address significant unmet medical needs.
Key details include:
- Company Presentation: April 26, 2023, from 11:00-11:30 AM ET.
- Webcast Link: Register here.
- Presenter: Jeremy Sobotta, CEO.
Perimeter aims to enhance surgical outcomes with its Perimeter S-Series OCT system and investigates the Perimeter B-Series OCT with cutting-edge AI technology, supported by a US$7.4 million grant for clinical trials.
- None.
- None.
TORONTO and DALLAS, April 18, 2023 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) ("Perimeter" or the "Company") – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – announced it will participate in one-on-one investor meetings and host a company presentation at the 2023 Bloom Burton & Co. Healthcare Investor Conference to be held in Toronto, Ontario from April 25-26, 2023.
Company Presentation Webcast Information:
Date: | Wednesday, April 26, 2023 |
Time: | 11:00-11:30 AM Eastern Time |
Webcast Link: | |
Presenter: | Jeremy Sobotta, Chief Executive Officer |
The above listed dates and times are subject to change. Details on company presentations and webcasts can be found on the Investors section of the Company's website. When available, webcasts will be posted for replay following the event.
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSXV: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT, Perimeter B-Series OCT, and Perimeter ImgAssist are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2021, which is available on Perimeter's SEDAR profile at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.
View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-to-present-at-the-2023-bloom-burton--co-healthcare-investor-conference-301800298.html
SOURCE Perimeter Medical Imaging AI, Inc.
FAQ
What is Perimeter Medical Imaging AI's participation in the 2023 Bloom Burton & Co. Healthcare Investor Conference?
When is Perimeter Medical Imaging AI's company presentation at the conference?
How can I watch the Perimeter Medical Imaging AI presentation online?
Who will present at the Perimeter Medical Imaging AI conference presentation?
What technologies is Perimeter Medical Imaging AI developing?
